B
enign soft-tissue lesions outnumber their malignant counterparts by a factor of 100:1, 1 but many are small and superficial and do not lead to imaging or biopsy. Softtissue sarcomas are estimated to represent 1% of malignant tumors. 2, 3 The incidence of soft-tissue sarcoma revealed a rate of 2.7 per 100,000. 4 The incidence of soft-tissue sarcoma increases significantly with age, and in patients 80 and older is 8 per 100,000. 5 Magnetic resonance (MR) imaging (MRI) is the favored modality for evaluation of soft-tissue tumors and tumor-like conditions. It is valuable for lesion detection, diagnosis, and staging. Although advances in thin-section computed tomography (CT) have recently allowed detailed multiplanar reconstructions, MRI allows superior soft-tissue contrast without radiation exposure.
When planning an MRI study for evaluation of a soft-tissue lesion at least 2 orthogonal planes should be obtained. In our experience lesions are typically best evaluated in the axial plane and this is usually the most familiar to radiologists. The secondary plane of imaging for an anterior or posterior lesion is typically the sagittal plane. Coronal sequences are optimal for evaluation of medial or lateral masses.
T1-weighted (T1W) and T2-weighted (T2W) sequences should be obtain as most soft-tissue lesions have been described with their spin-echo (SE) T1W and T2W signal characteristics. Fast SE sequences in place of SE sequences can reduce scanning time and patient motion artifacts. Gradientecho sequences can be useful in demonstrating hemosiderin with "blooming," but also is subject to artifact caused by metal, hemorrhage, and air. Short tau inversion recovery and T2 fat saturation images increase sensitivity to abnormal tissue containing increased water content. However, these techniques also reduce information concerning various tissue consistencies and should be used in the secondary, not the primary plane of imaging. The smallest diagnostic field of view is preferable when evaluating these lesions.
The use of intravenous contrast in lesion evaluation is controversial, but can be useful. Gadolinium contrast agents increase the T1W signal intensity of many soft-tissue tumors, allowing distinction between tumor and muscle or tumor and edema, but the surrounding area of edema may enhance as well. Information about tumor vascularity is also obtained. 6, 7 Contrast may allow distinction of small tumor nodules in a predominantly cystic lesion or a "spontaneous hematoma." Malignant lesions may show increased neovascularity at their periphery and high interstitial pressure at their center leading to a high rim-to-center differential enhancement ratio. 8 The use of intravenous contrast also increases the cost and length of time of the examination. Severe reactions to gadolinium and nephrogenic systemic fibrosis are rare, but they do occur.
Many investigators have evaluated if dynamic enhancement with gadolinium can help differentiate benign from malignant soft-tissue lesions. 6, 9, 10 High soft-tissue vascularity and perfusion demonstrates an increased rate of enhancement. Malignant lesions usually reveal greater enhancement and an increased rate of enhancement. 11 One difficulty with dynamic contrast-enhanced imaging is a significant overlap between the rate of enhancement of benign and malignant lesions. 12 We do not routinely perform dynamic enhancement sequences, at our institutions.
Although MR imaging is excellent at delineating soft-tissue lesions, a correct histologic diagnosis based on imaging studies alone is seen in only 25%-30% of cases. [13] [14] [15] However, we believe that this percentage continues to increase and ultimately will approach the 75%-90% range. 16 Most cases are nonspecific with intermediate T1 and intermediate to high T2 signal. A specific diagnosis should be obtained by using a combination of lesion signal intensity, location, growth pattern, and other unique characteristics of the lesion. Unless a specific diagnosis can be determined, the lesion should be considered indeterminate and an appropriate biopsy path should be discussed with the orthopedic oncologist or treating surgeon. A poorly selected biopsy path may violate compartments needed for reconstruction and an amputation may result.
Some authors have proposed that criteria such as tumor margins, homogenous vs. heterogeneous signal intensity, and lesion size can distinguish a benign from malignant lesion in greater than 90% of cases. 13 Other reports note malignant lesions can appear smoothly marginated and homogenous and MR appearance cannot accurately separate benign and malignant processes. 6, 14, 15, [17] [18] [19] Malignancies tend to grow pushing against adjacent structures and form a pseudocapsule as they enlarge. The pseudocapsule consists of compressed fibrous connective tissue, normal tissue, vascularization, and inflammatory reaction. Malignant lesions tend to respect anatomic compartments and fascial borders until late in their course. 20 Heterogeneous signal may represent mixed tissue types, necrosis, or hemorrhage within the lesion. Only a minority (5%) of benign soft-tissue tumors are greater than 5 cm in diameter and about 1% of benign lesions are deep. 5, 21 In general, well-defined, smooth margins, homogenous signal intensity, and small size are seen with benign lesions and irregular margins, heterogeneous signal and large size are indications of malignant lesions. Unless a specific diagnosis can be determined, a lesion should be considered indeterminate and an appropriate biopsy path should be discussed with the orthopedic oncologist or treating surgeon.
An intracompartmental lesion is one which has not crossed any natural anatomic boundaries, such as cortical bone, articular cartilage, joint capsule, fascial septa, tendon or ligament. Identification of invasion of other compartments is important for tumor staging and is often apparent on MR. More aggressive lesions more readily invade surrounding tissues and cross anatomic boundaries. Vascular channels and poorly planned biopsy paths may assist in invasion of adjacent compartments.
Lesion location is important for restricting the differential diagnosis. MRI with its excellent soft-tissue contrast is the most valuable modality for determining location. Lesion location includes intramuscular, intermuscular, subcutaneous, and intra-articular/periarticular. Multifocal or an extensive lesion also limits diagnostic considerations to include angiomatous lesions, neurofibromatosis, fibromatosis, lipomatosis, myxoma (Mazabraud syndrome), metastases, or lymphoma. The anatomic location may also aid in diagnosis, such as elastofibroma occurring deep to the scapular tip.
Lesions discussed in the following paragraphs are included for their frequency, specific location, or unique imaging characteristics allowing a specific diagnosis or a limited differential diagnosis. For the common but nonspecific lesions, a reasonable differential diagnosis requires knowledge of lesion prevalence, anatomic distribution, and age range. Lesions that predominantly affect pediatric patients are not discussed in this article.
Fibromatoses
Fibromatosis refers to a family of benign fibrous proliferations. The soft-tissue fibromatoses may be divided into superficial (fascial) and deep (musculoaponeurotic) lesions. These are benign lesions, but deep-seated lesions can display aggressive local biological behavior with rapid growth and frequent recurrence (19%-77% in the first 2 years), but no metastases. 22 In some cases, amputation may be necessary or patient demise may result from involvement of crucial structures.
Superficial FibromatosisPalmar and Plantar Fibroma
Palmar fibromatosis (Dupuytren disease) is the most common of the superficial fibromatoses, affecting 1%-2% of the population. 23, 24 These lesions occur 3-4 times more commonly in men and most frequently in patients aged more than 65 years (up to 20%). Bilateral lesions are present in up to 50% of cases. The lesions are painless, slow-growing palmar nodules, which may cause a flexion contracture, affecting the flexor tendons of the fourth and fifth fingers. 25 MR typically shows multiple nodular or cordlike superficial softtissue masses, which involve the aponeurosis of the volar aspect of the hand, extending superficially in parallel to the flexor tendons. Lesion signal intensity on T1W and T2W images is low (similar to tendon) reflecting hypocellularity and dense collagen. MR can be helpful for surgical planning as more immature lesions demonstrate intermediate to higher signal on T1W and T2W images, reflecting the high cellularity, and have a higher local recurrence rate after local resection. Mature lesions with low T1W and T2W signal intensity are less likely to locally recur. [26] [27] [28] Lesions show diffuse enhancement, which is more prominent in lesions with higher cellularity.
Plantar fibromatosis (Ledderhose disease) occurs less frequently than the palmar lesion, with an incidence of 0.23%. 29 In our experience, Ledderhose disease is more frequently imaged in our institutions than Dupuytren disease. It presents most frequently in patients aged 30-50 years. Men are affected twice as often as females, and lesions are bilateral in 20%-50% of cases. Associated palmar fibromatosis may be present in 10%-65% of cases. 30 Patients present with one or more subcutaneous nodules, which most frequently (78%) are found in the medial aspect of the plantar arch and can extend to the skin or deep structures of the foot. The lesions are typically painless, but may have pain with prolonged standing or walking. With MR imaging, superficial lesions along the deep plantar aponeurosis typically blend with the adjacent plantar musculature. Lesions typically show heterogeneous signal (92%), which is isointense to hypointense to skeletal muscle on T1W and T2W sequences (Fig. 1) . The degree of enhancement has been reported as marked in approximately 67% and mild in 33% of cases. 31 Linear tails of extension ("fascial tail sign") along the aponeurosis are frequent and best seen following contrast. 23, 26 
Deep Fibromatosis
The World Heath Organization in April 2002 designated the term desmoid-type fibromatosis for all deep fibromatoses. Desmoid tumor is a descriptive term from the Greek word desmos meaning "band" or "tendon." 23 Deep, or musculoaponeurotic, fibromatoses include extra-abdominal fibromatosis or aggressive fibromatosis (49%), abdominal fibromatosis (43%), and intra-abdominal fibromatosis (8%).
Intra-abdominal fibromatosis is the type most commonly associated with Gardner syndrome. 32, 33 Abdominal fibromatosis tends to occur in women during or immediately after pregnancy or with oral contraceptive use. Estrogen appears to be a stimulatory growth factor. 34 The most common locations of extra-abdominal fibromatosis in a large series by the AFIP are the shoulder/upper arm (28%), chest wall/paraspinal (17%), and thigh (12%). Desmoid-type fibromatosis is most common in the second and third decades with a peak incidence between the ages 25 and 35. 23, 35 Two to 4 people per million are affected with this lesion and less than 5% are seen in the pediatric age group. 24 There is a female predilection in younger patients, which equalizes in older patients. Desmoid type fibromatosis presents as a deep, firm, and poorly circumscribed soft-tissue mass, which is usually slow growing and painless. Lesions may be multicentric in 10%-15% of cases and may insinuate about vital neurovascular structures. 23 A skeletal dysplasia has been reported in 19% of patients with multicentric desmoid-type fibromatosis. MR is the optimal modality for evaluation of deep fibromatosis, due to its superior soft-tissue contrast. Lesions are usually centered intermuscularly with a rim of fat (split fat sign). Invasion of the surrounding muscle is frequent. The lesions are equally likely to be well defined or have irregular infiltrative margins. 36, 37 Linear extension along fascial planes (fascial tail sign) is a common manifestation (80% of cases). 37 The signal intensity of desmoid-type fibromatosis is quite variable reflecting the amount of collagen and degree of cellularity of the lesion. Immature lesions with marked cellularity reveal higher signal intensity on long repetition time (TR) images. In our experience, these lesions are also associated with a higher local recurrence rate after resection. More mature hypocellular lesions with abundant collagen reveal lower signal intensity on T1W and T2W sequences. 37, 38 Large studies of patients have shown the most common appearance of desmoid-type fibromatosis on MR is intermediate signal intensity on both T1W (similar to muscle) (83%-95% of cases) and T2W images (lower than fat but higher than muscle on images without fat suppression) (46%-77% of cases). 36, 37, [39] [40] [41] T1W and T2W sequences commonly show significant heterogeneity (Fig. 2) . Postcontrast images reveal moderate to marked heterogeneous enhancement with less than 10% of lesions lacking significant enhancement. 42 Although low-signal T2W areas are not specific for desmoid-type fibromatosis (See suggested differential later in the text) the bandlike morphology (low-signal bands are seen in 62%-91% of cases) of low signal intensity suggests the diagnosis. These low-signal bands are best observed on T2W or T1W fat-saturated images post contrast (the hypocellular collagenized bands do not enhance).
Differential diagnosis for soft-tissue lesions with areas of low signal intensity on T1W and T2W sequences includes desmoid-type fibromatosis, densely calcified masses, pigmented villonodular synovitis/giant cell tumor of tendon sheath (GCTTS), granular cell tumor, and malignant fibrous histiocytoma (MFH)/fibrosarcoma.
Elastofibroma
Elastofibroma dorsi is a slow-growing myofibroblastic pseudotumor and likely represents a reactive rather than neoplastic process. 23, 43 It is found between the inferior scapula tip and the chest wall in 95%-99% of cases. 44 The etiology is thought to be repetitive mechanical friction between the chest wall and scapular tip. These lesions were found in 24% of women and 11% of men in an autopsy series of patients greater than 55 years of age. 45 Most patients are older adults with peak incidence in the sixth and seventh decades. Lesions may be bilateral in 10%-66% of cases. 23 Most patients are asymptomatic. The most common symptom is stiffness, present in 25% of cases. There is a 2:1 female predominance. 44 A key imaging feature is entrapped fat within the lesion, which is well seen with CT or MR. T1W images show a crescentic, heterogeneous lesion with signal similar to adjacent skeletal muscle and streaks of high signal representing trapped fat (Fig. 3 ). Intermediate and heterogeneous signal is also present on T2W sequences and heterogeneous enhancement is common. Characteristic location with demonstration of entrapped fat is pathognomonic of elastofibroma. A differential diagnosis for lesions that are relatively hypocellular and contain abundant collagen would include elastofibroma, extra-abdominal desmoid-type fibromatosis, neurofibroma, and MFH/fibrosarcoma. 
Nodular Fasciitis
Nodular fasciitis is a benign soft-tissue lesion of unknown cause composed of proliferating fibroblasts. The lesion may grow rapidly and show high mitotic activity, simulating a more aggressive lesion. It is the most common benign tumor or tumorlike condition of fibrous tissue. It typically affects patients aged 20-40 years with no sex predilection. 37, 46, 47 Lesions typically present as a rapidly growing painless mass, although mild pain or tenderness may be present in approximately 50% of cases. 48 The upper extremity is involved in 46% of cases, particularly the volar forearm. Nodular fasciitis has 3 common locations: subcutaneous, fascial, and intramuscular. Lesions are subcutaneous between 3 and 10 times more frequently than other sites. The fascial form is the second most common and least frequent is the intramuscular type. The deeper intramuscular form is usually larger and is the most likely to be mistaken for sarcoma. 47, 49, 50 Most lesions show a maximal diameter of 2 cm or less. 51 On T1W images, nodular fasciitis has a signal intensity similar to or slightly higher than skeletal muscle (Fig. 4) . 49 With T2W sequences it is most often high signal intensity (greater than subcutaneous fat), but may demonstrate intermediate signal intensity. 50 Lesions are frequently homogeneous on T1W sequences and heterogeneous on longer TR acquisitions. 52 These lesions, as well as ancient schwannomas, are one of the few benign lesions that may demonstrate central necrosis, which may contribute to lesion heterogeneity. 23 Contrast enhancement was present in all cases in a series of 8 patients with a diffuse enhancement pattern in 67% of cases and peripheral enhancement in approximately 25%. 50 Linear extension along the fascia ("fascial tail sign") may suggest the diagnosis, and mild surrounding edema may also be present. 23 
Dermatofibrosarcoma Protuberans
Dermatofibrosarcoma protuberans constitutes approximately 6% of soft-tissue sarcomas. 53 The lesion is an intermediate grade malignancy, but fibrosarcomatous transformation may occur in 17%-27%. [54] [55] [56] Dermatofibrosarcoma protuberans most commonly occurs in the third to fifth decades of life. 57 Males are affected more frequently than females. The lesion presents as a slowly growing reddish brown to bluish superficial skin nodule. Large lesions may become painful. 58 The trunk is affected in up to 50% of cases followed up in frequency by the proximal upper and lower extremities. 59 MR demonstrates a lesion involving the skin and subcutaneous adipose tissue with a nodular or lobular architecture. The signal characteristics of the lesion are nonspecific, with signal similar to skeletal muscle on T1W images and similar to or greater than fat on T2W sequences (Fig. 5) . Moderate enhancement is seen after gadolinium enhancement. The lesion may show heterogeneous signal if hemorrhage or necrosis are present. Satellite nodules in the adjacent subcutaneous tissue may be present, and linear extensions along the skin are also often detected.
A differential diagnosis for a subcutaneous lesion would include cutaneous MFH/fibrosarcoma, dermatofibrosarcoma protuberans, skin adnexal/appendage tumor, and metastasis.
MFH/Fibrosarcoma
The World Heath Organization significantly reorganized the nomenclature of malignant fibrous lesions of the soft tissue in April 2002. The term MFH has been replaced by undifferentiated high-grade pleomorphic sarcoma. Giant cell MFH and inflammatory MFH are now called undifferentiated highgrade pleomorphic sarcoma with giant cells and undifferentiated high-grade pleomorphic sarcoma with prominent inflammation. Myxoid MFH is now called myxofibrosarcoma. 60 Having said this, most of our colleagues continue to use the term MFH either out of familiarity or because of the cumbersome new designations.
Fibrosarcoma is a low-to-intermediate grade malignant tumor of fibroblasts composing 5% of soft-tissue sarcomas. 23, 61 It occurs primarily in adults with 60% of patients aged 40-70 years. 62, 63 There is a male predilection (61% of cases). 64 It most commonly involves the deep soft tissues of the trunk. 62, 63, 65 Patients usually present with a painless mass slowly enlarging over several months duration and 30% of patients may have dull aching pain or tenderness. 62 MFH/undifferentiated high-grade pleomorphic sarcoma is a high-grade lesion of fibroblasts, myofibroblasts, or undifferentiated mesenchymal cells. 61 Subtypes include storiform and/or pleomorphic (50%-60%), myxoid (25%), giant cell (5%-10%), and inflammatory (Ͻ5%) types. 60 MFH is the most common soft-tissue sarcoma of adults accounting for 20%-30% of soft-tissue sarcomas and is the most frequent post radiation sarcoma. Peak incidence is in the fifth decade. There is a male predilection (70% of lesions). Patients usually present with an enlarging, painless soft-tissue mass with an average size of 5-10 cm. 61 Most common locations are the lower extremity (50%), upper extremity (25%), and retroperitoneum (15%). Lesions are most commonly in a deep intramuscular location (70%) with 5%-10% being subcutaneous. 66 Imaging features of adult fibrosarcoma and MFH are indistinguishable and described together. Lesions are typically seen as an intramuscular mass with intermediate intensity on T1W and intermediate-to-high (greater than fat) signal on T2W images (Fig. 6) . The lesions are heterogeneous on all pulse sequences reflecting variable amounts of collagen, myxoid tissue, necrosis, and hemorrhage. Low signal regions on T2W sequences presumably represent areas of high collagen content. The lesion margin is usually well defined because of a fibrous pseudocapsule. MFH and/or fibrosarcoma typically show enhancement, which may be heterogeneous if areas of necrosis or hemorrhage are present. Destruction of adjacent cortical bone may be present, similar to synovial sarcoma. [66] [67] [68] [69] When there is history of a spontaneous hematoma, be suspicious of an underlying neoplasm (particularly MFH or synovial sarcoma) and look for solid or nodular enhancing components, usually in the periphery. Hematomas reveal thick non-nodular walls often containing hemosiderin. Edema is often seen surrounding a hematoma secondary to irritation from the blood, but a tumor that hemorrhages typically retains the blood within the pseudocapsule and edema is not a prominent feature. 60, 66 
Lipoma
Lipoma is the most common soft-tissue neoplasm and represents about 50% of all soft-tissue tumors. The incidence is approximately 2.1 per 100 people. 21, 70 Lipoma is more common than liposarcoma by a ratio of 100:1. 21, 71, 72 Most lipomas are discrete masses categorized by anatomic location as superficial (subcutaneous) or deep. Deep lipomas are much less common and account for approximately 1% of lipomas. 73 Superficial lipoma typically present in the fifth and sixth decades with 80% of lesions in patients aged 26-65 years. 72 Both males and females have been reported as more commonly affected, but there is no clear-cut sex predilection. 71, 74, 75 Lesions are typically small with 80% less than 5 cm. 71 Superficial lipomas are most commonly located in the trunk, shoulders, upper arm, and neck. 71 Superficial lipoma is often difficult to distinguish from the surrounding cutaneous tissue, particularly if the lesion is "nonencapsulated." Therefore, we prefer to place a fiducial marker over superficial lesions, position the patient so the lesion is not compressed, and compare the area to the contralateral side.
Deep lipomas (including the intramuscular and intermuscular lipomatous tumors) occur most commonly in patients aged 20-60 years. Men are affected more frequently than women, and lesions commonly affect the large muscles of the lower extremity (45%), trunk (17%), and shoulder (12%). Lipomas of the retroperitoneum are rare and a lipomatous lesion in this location should be treated as a liposarcoma. 53, 72 The size range of lipoma is large and lesions can measure up to 20 cm. 21, 71, 72 Superficial and deep lipoma often present with a painless, slow-growing soft-tissue mass. 75 Lipomas may be multiple in 5%-15% of patients. 21, 23, 71, 74 Weiss and Goldblum separate deep lipomas from the intramuscular and intermuscular lipomatous tumors, 76 but we group all lipomatous lesions found beneath the superficial fascia together as deep lipomas. Deep lipoma involving the extremity is most commonly intramuscular. 77 Lipomas most commonly demonstrate signal characteristics identical to subcutaneous fat on all pulse sequences with high signal on T1W and T2W sequences with minimal (Ͻ2 mm) septations, however 28%-30% may have thick septa or nodularity similar to liposarcoma (Fig. 7) . 78 Intramuscular lipomas may have irregular margins, which interdigitate with the adjacent skeletal muscle referred to as "infiltrating lipoma." There should be no significant enhancement of the lesion after contrast administration. 23 Differential diagnosis for a lipomatous lesion with mild complexity includes lipoma, angiolipoma, myolipoma, chondroid lipoma, lipoblastoma, spindle cell/pleomorphic lipoma, hibernoma, and well-differentiated liposarcoma.
Liposarcoma
The World Heath Organization has reorganized the nomenclature of malignant lipomatous lesions of soft tissue in April 2002. Current subtypes of liposarcoma include well-differentiated liposarcoma, dedifferentiated liposarcoma, myxoid liposarcoma, pleomorphic liposarcoma, and mixed-type liposarcoma. The previous lesion referred to as round cell liposarcoma has been incorporated into the category of myxoid liposarcoma. 60 Liposarcoma is the second most common soft-tissue sarcoma after MFH. 53 The estimated annual incidence is 2.5 per million population. 79 
Well-Differentiated Liposarcoma
Well-differentiated liposarcoma is a low-grade malignancy, which recurs locally, but does not metastasize. 78 It is the most common subtype representing about 50% of all liposarcomas. 79 There is an equal sex distribution. This lesion is not seen in patients aged less than 10 years and the peak prevalence is in the sixth and seventh decades. 78 Common lesion locations include the lower extremities (50%), retroperitoneum (20%-33%), upper extremity (14%), and trunk (12%). 78, 80 Retroperitoneal lesions have up to a 91% local recurrence rate after resection. Lesions are most frequently intramuscular, but they can occur in intermuscular and subcutaneous locations. 78, 81 With MR, well-differentiated liposarcoma is a mass composed of greater than 75% adipose tissue, but with significant nonadipose components seen as prominent thick septa and focal nodular regions usually less than 2 cm in size (Fig. 8) . [82] [83] [84] [85] [86] Nodular nonlipomatous components of size greater than 3 cm suggest dedifferentiated liposarcoma. 78 Moderate to marked enhancement may be seen in the nonlipomatous thickened septa and nodular areas. 82 The lesion can be difficult to distinguish from lipoma. Statistical factors favoring the diagnosis of well-differentiated liposarcoma as opposed to lipoma include male sex, age greater than 66 years, lower percentage of fat in the lesion, mineralization, size greater than 10 cm, greater than 2 mm thick septa, or nonlipomatous nodular or globular foci. 86 A differential diagnosis for soft-tissue lesions with components of relatively high signal intensity on T1W images may include lipoma/well-differentiated liposarcoma, clear cell sarcoma, melanotic melanoma, alveolar soft part sarcoma, hemangioma, and subacute hemorrhage.
Myxoid Liposarcoma
Myxoid liposarcoma is an intermediate to high-grade malignancy depending on the percentage of round cell component. It is the second most common type of liposarcoma representing 20%-50% of all liposarcomas. 78, [87] [88] [89] Myxoid liposarcomas account for 10% of all soft-tissue sarcomas. 90 Peak prevalence is from the forth to fifth decades of life. These lesions show no gender predilection 78 and predominantly affect the lower extremity (75%-80% of cases), particularly the popliteal region and medial thigh. Extremity myxoid liposarcoma are most frequently intermuscular (70%-80% of cases). Intramuscular and subcutaneous lesions are less common. 23, 79, 81, [87] [88] [89] Clinical presentation of myxoid liposarcoma is that of a painless soft-tissue mass. On MR, these lesions are typically large, well-defined, and multilobulated (Fig. 9) . Low signal intensity T1W images and marked high signal T2W sequences reflect the high water content of the lesion and these features may mimic a cyst. Adipose tissue with high T1W signal typically constitutes a small volume of the lesion (Ͻ10%) with a lacy or linear pattern. In our experience, approximately 90% of myxoid liposarcomas demonstrate fat on an MR image. Identification of the subtle fat component may require comparison of T1W and T2W images in the same plane. 78 tion from a cystic lesion. Round cell components may reveal more marked diffuse enhancement. 93 Differential diagnosis for a predominantly myxoid appearing soft-tissue lesion includes; myxoid liposarcoma, myxofibrosarcoma (or myxoid MFH), myxoid chondrosarcoma, myxoma, ganglion cyst, synovial cyst/bursa, and peripheral nerve sheath tumor.
Benign Peripheral Nerve Sheath Tumor
Benign peripheral nerve sheath tumors (BPNSTs) are typically divided into schwannoma (neurilemoma) and neurofibroma. 61 Both lesions contain cells closely related to the normal Schwann cell.
Schwannoma is slightly less common than neurofibroma and comprises approximately 5% of all benign soft-tissue tumors. 72 Schwannoma is most commonly seen in patients aged 20-50 years with an equal sex distribution. 61, 94 Schwannoma is usually a slow growing, nonaggressive lesion that presents as a painless mass of size less than 5 cm. Pain may be associated with larger lesions. 23 Common sites of involvement include the cutaneous nerves of the head, neck, and flexor surface of the extremities. Posterior mediastinum and retroperitoneum are frequent locations for deep-seated lesions. 61 Schwannoma may be plexiform or multiple in ap- proximately 5% of cases. 95 Lesions are sporadic in 90% of cases; 3% occur with neurofibromatosis type 2 (NF2) and 2% occur with schwannomatosis. 96 The lesion is typically separable from the adjacent nerve after incising the epineurium and nerve function is thus preserved after resection. 23 Neurofibroma constitutes slightly more than 5% of benign soft-tissue tumors. 72 Neurofibroma is most commonly seen in patients aged between 20 and 30 years and demonstrates no sex predilection. 61, 94 Three types of neurofibroma are classically described, including localized (90%), diffuse, and plexiform. 23, 72 Superficial cutaneous or deep-seated nerves may be involved. Localized neurofibromas are usually a slowgrowing, painless masses measuring less than 5 cm. The diffuse type primarily affects children and young adults and most frequently involves the subcutaneous tissue of the head and neck and only 10% are associated with neurofibromatosis type 1 (NF1). 23, 72 Neurofibroma, unlike schwannoma, cannot be separated from the nerve and complete excision of the neoplasm requires sacrifice of the nerve. 97 NF1 is seen in 1 of every 2500-3000 births. 98, 99 Males are more commonly affected. 61 NF1 demonstrates multiple local neurofibromas and frequently plexiform lesions. These lesions occur anywhere in the body, both superficial and deep. Plexiform neurofibroma represents diffuse involvement of a long segment of nerve giving a "ropelike" or "bag of worms" appearance and is pathognomonic of NF1. The incidence of malignant transformation to malignant peripheral nerve sheath tumor (MPNST) is between 2% and 29% in patients with NF1.
On MR, the signal intensity of localized lesions is nonspecific and will be similar to or lower than muscle on T1-weighted images and higher than fat on T2-weighted images (Fig. 10) . Recognition of the well-defined, fusiform shape of the lesion can be very helpful to identify the lesion as BPNST, which is caused by the tubular entering and exiting nerve. With schwannoma, the entering and exiting nerve may be eccentric to the soft-tissue mass. Diffuse neurofibroma may show predominant low T2W signal, which may be related to the high collagen content. Heterogeneity of BPNST is variable, particularly with hemorrhage, necrosis, and areas of degeneration seen in the ancient schwannomas. 23 The "target sign" is almost pathognomonic for neurofibroma (70% of cases), but can be seen with schwannoma. It refers to low-tointermediate T2W signal centrally secondary to more fibrous tissue and high T2W signal peripherally likely related to myxoid tissue (Fig. 10D) . 100 The central fibrous areas have marked contrast enhancement. [100] [101] [102] [103] The "fascicular sign" manifests as multiple ringlike structures seen on T2W or proton density-weighted images and is seen in superficial and deep-seated lesions. 23 A rim of fat (split fat sign) is often seen with deep-seated BPNSTs, but is nonspecific and can be seen in many intermuscular lesions. 104 
Malignant Peripheral Nerve Sheath Tumor
MPNST accounts for 5%-10% of soft-tissue sarcomas. It usually affects patients aged 20-50 years, with a slight female predilection. It is associated with NF1 in 25%-70% of cases, where it presents about a decade earlier with a male predilection (80%). 61 Patients present with pain and neurologic symptoms of motor weakness more frequently than those with BPNST. A sudden increase in size of a previously stable lesion should also raise suspicion for MPNST. MPNST usually affects medium to large deep-seated nerves with the sciatic nerve, brachial plexus, and sacral plexus most commonly involved. 105 These lesions are typically greater than 5 cm in size, whereas BPNSTs are frequently less than 5 cm. Distinguishing MPNST and BPNST by imaging can be challenging as the lesions can appear very similar. There are some imaging features that may be helpful. The "target sign" and "fascicular sign" are uncommon in MPNST (Fig. 11) . Margins of MPNST may be ill-defined. Central necrosis is more common in the malignant lesion, but can be seen with ancient schwannoma. 23 One study suggests that MPNST and PNST cannot be adequately separated by evaluation of lesion heterogeneity. 106 Enhancement of the benign lesion is variable and prominent enhancement is noted in the malignant lesion. 23 More recently PET imaging, including the use of 11 C methionine has been suggested as useful in this distinction as well. 107-109 
Synovial Sarcoma
Synovial sarcoma is an intermediate to high-grade neoplasm with extensive metastatic potential. 110 This lesion accounts for about 5%-10% of soft-tissue sarcomas. It is typically seen in young adults aged between 15 and 35 years with the mean patient age of 32, although there is a wide age range, including newborns. Males and females are affected equally. 53, 111, 112 Patients with synovial sarcoma may initially present with a palpable slow-growing mass, which can simulate a benign process. 113 In contrast to most other soft-tissue malignancies, pain is often present. The duration of symptom may vary from days to as long as 20 years before initial diagnosis. 114 Synovial sarcomas are most commonly located in the lower extremities (60%-70%) and 80%-95% are in the extremities (often occurring near a joint). 111, 114 The popliteal fossa is the most frequent location. 110 Most synovial sarcomas are centered in an intermuscular location. It is the most common malignancy of the foot and ankle in patients aged 6-45 years. 53 Despite the name, the tumor does not arise from the synovium, and fewer than 10% of cases are intra-articular. Lesions demonstrate calcification, often in the periphery of the tumor, on radiographs in up to 30% of cases. These calcifications are difficult to appreciate on MR. Other softtissue lesions, which commonly demonstrate calcification include soft-tissue osteosarcoma/chondrosarcoma, chondroma, myositis ossificans, and leiomyosarcoma. Synovial sarcomas are typically heterogeneous, with signal similar to skeletal muscle on T1W sequences and equal to or greater than subcutaneous fat on T2W images (Fig. 12) . The heterogeneity of these lesions is depicted as the "triple sign" in 30%-50% of cases, with areas that are hyperintense, isointense, and hypointense to fat on T2W sequences. 115 This finding is presumably the result of a mixture of solid cellular elements, hemorrhage or necrosis, and calcified or fibrotic collagenized areas. 116, 117 A multiloculated appearance with internal septations may also be present. 117 Hemorrhage is present in more than 40% of patients with fluid levels in 10%-25% of lesions on MR imaging. [115] [116] [117] A combination of hemorrhage, fluid levels and septa may also cause the "bowl of grapes" sign. 110 Cortical erosion or marrow invasion may be seen on MR in up to 21% of cases. 115, 117 Contrast enhancement is usually prominent and heterogeneous, and can be very important to demonstrate small areas of nodular enhancement in a predominantly cystic lesion that may otherwise be mistaken for a benign cyst. Serpentine vascular channels can be noted in approximately 30% of cases. 110 Differential diagnosis for soft-tissue lesions with fluid levels includes synovial sarcoma, hemangioma, myositis ossificans, hematoma, and lymphangioma.
Pigmented Villonodular Synovitis and GCTTS
Pigmented villonodular synovitis (PVNS) and GCTTS are benign synovial proliferative lesions of the joint and tendon sheath, respectively. These lesions are believed to be neoplas- tic rather than reactive. 111, 118 They are divided according to their location (intra-articular vs extra-articular) and their pattern of growth (localized or diffuse). 23 Localized disease, both extraarticular and intraarticular, represents 77% of cases (the tenosynovial form being the most common), compared with diffuse intraarticular involvement, which accounts for 23%. Patients are typically adult, with the peak incidence in the third to fifth decades and there is a slight female predominance. [119] [120] [121] [122] Clinical symptoms include soft-tissue swelling or a slowly enlarging, painless soft-tissue mass, which is freely mobile. 72, 119, 120, 122 Pain may be aggravated by activity. 121 Most of these lesions occur in the hand and wrist (65%-89%). It is one of the most common soft-tissue masses in the hand, second in frequency only to ganglion. 120, 123 In the hand, the lesion more commonly affects the volar aspect of the digits. The foot and ankle location accounts for 5%-15% of lesions. MR frequently demonstrates a nonspecific welldefined soft-tissue mass adjacent to and partially surrounding the tendon. Lesions are approximately equal to or less than skeletal muscle on T1W. On T2W images, lesions are heterogeneous with signal intensity equal to or less than fat. 124 Marked enhancement is noted in most cases. 125 Osseous pressure erosions may be present in 15%-20% of cases.
Pigmented villonodular synovitis is most common in the third and fourth decades. It has equal frequency in men and women, with an annual incidence of approximately 2 per million. 126 Symptoms include mechanical pain aggravated by motion and improves with rest. Swell- ing and limited range of motion may also be experienced. 127 PVNS most frequently affects the large joints, with about 75%-80% occurring in the knee. Other joints involved in decreasing order of frequency are the hip, ankle, shoulder, and elbow. [128] [129] [130] Tumor recurrence after surgery is common. Geographic, lytic osseous erosions with sclerotic borders are most common in the hip (93%) and shoulder (75%) because of their smaller capacity. Bone marrow edema may be noted at sites of osseous erosion, but the joint space is usually preserved. 128, 129 MR shows a diffuse, multinodular intra-articular synovialbased mass (Fig. 13) . Lesions are approximately equal to or less than skeletal muscle on T1W. There is predominantly decreased signal intensity on T2W images resulting from the hemosiderin with scattered areas of high T2W signal. 126, 131, 132 PVNS reveals susceptibility artifact ("blooming") on gradient echo sequences, which may help to distinguish the lesion from other causes of diffuse synovial thickening. 133 Intense contrast enhancement is typical, but may vary depending on the amount of fibrosis and hemosiderin in the lesion. 134, 135 There is typically an associated joint effusion, which may be prominent. 131 
Hemangioma and/or Vascular Malformations
We tend to combine hemangiomas and vascular malformations into one category for discussion. Hemangiomas and/or vascular malformations are among the most frequent tumors to involve the soft tissue and comprise 7% of all benign tumors. Hemangioma is the most common tu- mor in infancy and childhood. 61, 94, 136 It is estimated 1%-2% of the general population and 10% of Caucasians are affected. 137 Hemangiomas are more common in women with a 3:1 ratio. 23 Lesions may increase dramatically in size during pregnancy. Soft-tissue hemangioma may be superficial or deep, with the deep lesions most frequently intramuscular. Clinical presentation is often a painful lesion that intermittently changes in size. Pain associated with intramuscular hemangioma is often vague and related to exercise. Hemangioma are frequently subdivided based on the predominant type of vascular channel (capillary, cavernous, arteriovenous, or venous). 61 Cavernous hemangiomas frequently calcify with dystrophic mineralization and organizing thrombus (phlebolith) best seen on radiographs or CT. On T1W images, intramuscular hemangioma may be defined or a poorly marginated mass of low-to-intermediate signal intensity with areas of high signal intensity related to fat or slow-flowing blood (Fig. 14) . These high signal intensity areas vary from fine lacelike strands to thick course bands. The fat may be so extensive as to simulate lipoma. [138] [139] [140] [141] [142] [143] On T2W sequences, the lesion may be a well-marginated or infiltrative mass with very high signal intensity owing to slow blood flow in vascular components in most lesions and intermediate signal corresponding to adipose tissue. The circular vessels seen en face and linear vessels seen longitudinally with adjacent fat overgrowth have a characteristic appearance. These lesions tend to be heterogeneous on all pulse sequences and they frequently infiltrate rather than displace adjacent tissues. 144 
Hemangioendothelioma, Hemangiopericytoma, and Angiosarcoma
Hemangioendothelioma is a vascular neoplasm of intermediate aggressiveness between hemangioma and angiosarcoma. Hemangioendothelioma occurs in young patients and involves soft tissue more often than bone. Soft-tissue hemangioendothelioma usually involves the deep tissues of the extremities, with approximately 50% of the cases being closely related to a vessel from which they may have arisen. 144 Hemangiopericytoma is a vascular neoplasm of intermediate aggressiveness with benign and malignant forms. The highest incidence is in middle-aged adults. 61 Hemangiopericytoma commonly involves the lower extremity (35% of cases), most often the soft tissue of the thigh. The pelvis and retroperitoneum are involved in 25% of cases. The tumor often demonstrates large vessels, predominantly in the periphery. 144 Angiosarcoma is an aggressive, vascular malignancy with high local recurrence and distant metastases. Male to female predilection is 2:1. Angiosarcomas involve the skin (33%), soft tissues (24%), and bone (6%). Angiosarcoma is related to chronic lymphedema in 10% of cases. 61, 144 It is usually not possible to differentiate hemangioendothelioma, hemangiopericytoma, and angiosarcoma radiologically. The MR signal characteristics are intermediate signal on T1 and high signal on long TR sequences (Fig. 15) . These lesions demonstrate aggressive infiltration of the adjacent tissues. Areas of hemorrhage with high T1W signal may be seen. Prominent serpentine vascular channels in the periphery of the lesion can suggest the diagnosis and are seen most frequently with hemangiopericytoma. The signal intensity of these vascular structures may reflect high flow (low signal on all pulse sequences) or low flow (high signal on T2W images). 144 Differential diagnosis for a soft-tissue mass with prominent vascular channels includes alveolar soft part sarcoma, metastatic renal cell carcinoma, hemangiopericytoma, hemangioendothelioma, rhabdomyosarcoma, extraskeletal Ewing sarcoma, and synovial sarcoma.
Leiomyosarcoma
Leiomyosarcoma is a high-grade malignancy, which represents approximately 9% of all soft-tissue sarcomas. 53, 145 Patients with soft-tissue leiomyosarcoma have a median age in the fifth to sixth decades. [146] [147] [148] Retroperitoneal lesions (20% of cases) are more common in females 2:1 to 7:1, and there is a male predilection for peripheral lesions (12% of cases). 148 Retroperitoneal lesions present clinically as an abdominal mass and swelling with pain in less than 10%. 147 It is the second most common retroperitoneal tumor after liposarcoma. 149 Extremity lesions present with a painless slowly enlarging mass most commonly affecting the thigh. 146 Imaging of leiomyosarcoma is typically nonspecific. Mineralization on radiograph has been reported in 17% of cases. 150 Lesions are typically isointense to muscle on T1-weighted images and 
